![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » Cardiva Medical’s Vascular Closure System Finds Further Approval
Cardiva Medical’s Vascular Closure System Finds Further Approval
![Purple_Approved_Stamp.gif](https://www.fdanews.com/ext/resources/test/Drug-Images4/Purple_Approved_Stamp.gif?t=1576639773&width=430)
April 6, 2018
The FDA approved an expanded indication for Cardiva Medical’s Vascade vascular closure system, allowing it to be used for 5-7F femoral venous closures after being previously approved for arterial closures.
The vascular closure system is intended for patients undergoing interventional cardiac catheterization procedures.
The device consists of a collagen patch and proprietary collapsible disk that are clinically proven to achieve hemostasis while minimizing complications. It does not require prolonged heavy pressure or extended bed rest.
Upcoming Events
-
21Oct